These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25585568)

  • 1. NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells.
    Gordon CA; Gulzar ZG; Brooks JD
    Prostate; 2015 Apr; 75(5):517-26. PubMed ID: 25585568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
    Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
    Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis.
    Sun L; Shi C; Liu S; Zhang E; Yan L; Ji C; Zhao Y
    Gene; 2020 Jul; 747():144657. PubMed ID: 32298762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUSAP1 promotes invasion and metastasis of prostate cancer.
    Gordon CA; Gong X; Ganesh D; Brooks JD
    Oncotarget; 2017 May; 8(18):29935-29950. PubMed ID: 28404898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.
    Gulzar ZG; McKenney JK; Brooks JD
    Oncogene; 2013 Jan; 32(1):70-7. PubMed ID: 22349817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling.
    Xu Z; Wang Y; Xiong J; Cui F; Wang L; Peng H
    J Cell Physiol; 2020 Apr; 235(4):3886-3893. PubMed ID: 31603257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
    Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of TFDP3 on regulating the autophagy and apoptosis of LNCaP cells].
    Ren LF; Ma YY; Yue QH; Su MQ; Hao XK
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):347-9. PubMed ID: 22482402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.
    Hahm ER; Singh SV
    Mol Cancer Ther; 2007 Oct; 6(10):2686-95. PubMed ID: 17938262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells.
    Tsui KH; Chang YL; Feng TH; Chung LC; Lee TY; Chang PL; Juang HH
    J Mol Endocrinol; 2012 Oct; 49(2):153-63. PubMed ID: 22872134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
    Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
    Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).
    Gong H; Zhou L; Khelfat L; Qiu G; Wang Y; Mao K; Chen W
    Med Sci Monit; 2019 Apr; 25():3090-3099. PubMed ID: 31026254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
    Pappas L; Xu XL; Abramson DH; Jhanwar SC
    Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation.
    Ren Z; Kang W; Wang L; Sun B; Ma J; Zheng C; Sun J; Tian Z; Yang X; Xiao W
    Mol Cancer; 2014 Apr; 13():84. PubMed ID: 24742333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NUSAP1 gene silencing inhibits cell proliferation, migration and invasion through inhibiting DNMT1 gene expression in human colorectal cancer.
    Han G; Wei Z; Cui H; Zhang W; Wei X; Lu Z; Bai X
    Exp Cell Res; 2018 Jun; 367(2):216-221. PubMed ID: 29608915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
    Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
    BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.
    Kang DW; Lee SW; Hwang WC; Lee BH; Choi YS; Suh YA; Choi KY; Min DS
    Cancer Res; 2017 Jan; 77(1):142-152. PubMed ID: 27793841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.
    Ge Y; Li Q; Lin L; Jiang M; Shi L; Wang B; Yang L; Xu Z
    Cell Biochem Funct; 2020 Jan; 38(1):28-37. PubMed ID: 31710389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar and spindle associated protein 1 promotes the aggressiveness of astrocytoma by activating the Hedgehog signaling pathway.
    Wu X; Xu B; Yang C; Wang W; Zhong D; Zhao Z; He L; Hu Y; Jiang L; Li J; Song L; Zhang W
    J Exp Clin Cancer Res; 2017 Sep; 36(1):127. PubMed ID: 28899410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.